Li Xiaoyu X - OmicsDI

Show results for

Proteomics (31)
Unknown (7)
Metabolomics (5)
Transcriptomics (4)
Multiomics (2)
Genomics (1)
Other (1)

Organisms

Homo sapiens (16)
Mus musculus (3)
Aeromonas bestiarum (3)
Scophthalmus maximus (3)
Tupaia belangeri (3)
Enterococcus faecalis str. Symbioflor 1 (3)
Bathymodiolus thermophilus (3)
Aeromonas rivuli (3)
Clonorchis sinensis (3)
Bacillus cytotoxicus (3)
Pseudomonas aeruginosa ATCC 15442 (3)
Amphistegina (3)
Colwellia psychrerythraea (3)
Legionella pneumophila (3)
Synechocystis sp. PCC 6803 substr. GT-I (3)
Caldalkalibacillus thermarum TA2.A1 (3)
Rhipicephalus pulchellus (3)
Tettigonia cantans (3)
Symbiodinium sp. ex Acropora millepora (3)
Bacillariophyta (3)
Oryza sativa (2)
Bombyx mori (1)
Gallus gallus (1)
Arabidopsis thaliana (1)
Octocorallia (1)
Streptococcus pneumoniae 23F (1)
Ricinus communis (1)
Saccharomyces cerevisiae S288C (1)
Fusobacterium nucleatum subsp. nucleatum ATCC 25586 (1)
Oryctolagus cuniculus (1)

Repository

iProX (22)
MassIVE (6)
biostudies-arrayexpress (5)
MetaboLights (5)
pride (3)
GPMDB (1)

Tissue

Cell culture (3)
Early embryonic cell (1)
Epithelial cell (1)

Disease

Not Available (1)
Breast cancer (1)

Technology Type

Mass spectrometry (4)
Mass Spectrometry (3)
Mass spectrometry assay (1)
Gel-based experiment (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Shotgun proteomics (1)

Instrument Platform

LTQ Orbitrap (2)
Q Exactive (2)
Liquid Chromatography MS - negative (2)
Liquid Chromatography MS - positive (2)
Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Instrument (1)
LTQ Orbitrap Velos (1)
Orbitrap Fusion Lumos (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)

Publication Date

2022 (9)
2024 (6)
2025 (4)
2023 (4)
2015 (3)
2014 (3)
2026 (3)
2010 (2)
2020 (2)
2018 (2)
2012 (1)
2021 (1)
2017 (1)

CHEBI ID

CHEBI:18211 (3)
CHEBI:18089 (3)
CHEBI:17533 (3)
CHEBI:21557 (2)
CHEBI:34498 (2)
CHEBI:16259 (2)
CHEBI:17566 (2)
CHEBI:64563 (2)
CHEBI:16010 (2)
CHEBI:30746 (2)
CHEBI:16704 (2)
CHEBI:16811 (2)
CHEBI:17568 (2)
CHEBI:16742 (2)
CHEBI:28834 (2)
CHEBI:18295 (2)
CHEBI:64294 (2)
CHEBI:17295 (2)
CHEBI:17015 (2)
CHEBI:16919 (2)
CHEBI:15891 (2)
CHEBI:7916 (2)
CHEBI:6650 (2)
CHEBI:18237 (2)
CHEBI:18012 (2)
CHEBI:30915 (2)
CHEBI:60050 (1)
CHEBI:229940 (1)
CHEBI:190147 (1)
CHEBI:39745 (1)

Metabolite Name

Hippuric acid (3)
Orotic acid (2)
Citrulline (2)
Pyroglutamic acid (2)
N-Acetyl-L-methionine (2)
Taurine (2)
Uracil (2)
Deoxycholic acid (2)
Benzoic acid (2)
N-Acetyl-L-phenylalanine (2)
L-Phenylalanine (2)
Pantothenic acid (2)
Malic acid (2)
Fumaric acid (2)
Uridine (2)
Triiodothyronine (1)
3,4,5,6-tetrahydroxyoxane-2-carboxylic acid (1)
D-2,3-Dihydroxypropanoic acid (1)
Isohyodeoxycholic acid (1)
[10]-Dehydrogingerdione (1)
Trans-Cinnamic acid (1)
3-Methoxy-4-hydroxyphenylethyleneglycol sulfate (1)
9-Decenoic acid (1)
Ethyl hexadecanoate (1)
8,15-DiHETE (1)
Trans-urocanate (1)
15-Keto-13,14-dihydroprostaglandin A2 (1)
Alpha-CEHC (1)
5a-Tetrahydrocorticosterone (1)
Carbadox (1)

Study type

Transcription profiling by array (2)
RNA-seq of coding RNA (2)
Methylation profiling by high throughput sequencing (1)

Release Date

2024 (3)
2015 (2)
2010 (2)
2022 (2)
2014 (1)
2012 (1)
2018 (1)

Lab affiliation

State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences (1)
Institute of Systems Biomedicine, Peking University Health Science Center, Beijing 100191, China. (1)
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China (lab head) (1)

Previous page
1 / 5
You're on page 1
page 2
page 3
page 4
page 5
Next page

Sort by:

Relevance

Page size

A novel Saclayvirus Acinetobacter baumannii phage genomic analysis and effectiveness in preventing pneumonia.

Not available

S-EPMC11283397 | biostudies-literature

Selective killing of cancer cells by a small molecule targeting the stress response to ROS

Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SW. Nature. 2011 475:231-4. doi: 10.1038/nature10167. PMCID: PMC3316487

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2014-01-27 | MSV000078537 | MassIVE

METTL3 Regulates the Inflammatory Response in CPB2 Toxin-Exposed IPEC-J2 Cells through the TLR2/NF-κB Signaling Pathway.

Not available

S-EPMC9781724 | biostudies-literature

Examination of whole genome DNA methylation status of two chicken breeds

We report the genome-wide DNA methylation mapping of chicken by methylated DNA immunoprecipitation following by highthroughput sequencing, and the gene expression profile of chicken by RNA-seq. For meDIP-seq, about 17,202,074 to 27,501,760 reads were generated for the tissue and liver tissues of the...

ORGANISM(S): Gallus gallus

2010-04-02 | E-GEOD-21167 | biostudies-arrayexpress

Clinical efficacy of Yiqi Yangxue formula on knee osteoarthritis and unraveling therapeutic mechanism through plasma metabolites in rats.

OBJECTIVE: To observe the clinical efficacy and safety of Yiqi Yangxue formula (YQYXF) on knee osteoarthritis (KOA), and to explore the underlying therapeutic mechanism of YQYXF through endogenous differential metabolites and their related metabolic pathways.

METHOD...

2024-03-25 | MTBLS5667 | MetaboLights

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

Krönke J, Udeshi ND, Narla A, Grauman P, Hurst SN, McConkey M, Svinkina T, Heckl D, Comer E, Li X, Ciarlo C, Hartman E, Munshi N, Schenone M, Schreiber SL, Carr SA, Ebert BL. Science 2014, 343, 301-305. doi:10.1126/science.1244851. Lenalidomide is a drug with clinical efficacy in multiple myeloma an...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2015-01-26 | MSV000079017 | MassIVE

Single-cell metabolic fingerprints discover a cluster of circulating tumor cells with distinct metastatic potential

Circulating tumor cells (CTCs) are recognized as direct seeds of metastasis. However, CTC count may not be the 'best' indicator of metastatic risk because their heterogeneity is generally neglected. In this study, we develop a molecular typing system to predict colorectal cancer metastasis potent...

2023-08-21 | MTBLS5028 | MetaboLights

Identification of regulators of polyploidization presents therapeutic targetsfor treatment of AMKL

Wen Q, Goldenson B, Silver SJ, Schenone M, Dancik V, Huang Z, Wang LZ, Lewis TA, An WF, Li X, Bray MA, Thiollier C, Diebold L, Gilles L, Vokes MS, Moore CB, Bliss-Moreau M, Verplank L, Tolliday NJ, Mishra R, Vemula S, Shi J, Wei L, Kapur R, Lopez CK, Gerby B, Ballerini P, Pflumio F, Gilliland DG, Go...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2014-01-27 | MSV000078536 | MassIVE

Enhanced Salicylic Acid Biosynthesis Is Involved in Heterosis for Bacterial Defense in Arabidopsis

We provide evidence that heterosis for bacterial defense exists in hybrids crossed between some Arabidopsis accessions. Comparison of transcriptomes between hybrids exhibiting heterosis for disease resistance and their parents after inoculation with Pst DC3000 revealed that several key genes involve...

ORGANISM(S): Arabidopsis thaliana

2015-06-02 | E-GEOD-62256 | biostudies-arrayexpress

A global analysis of QTLs for expression variations in rice flag leaf at heading date

Analyses of QTLs for expression levels (eQTLs) of the genes reveal genetic relationship between expression variation and the regulator, thus unlocking the information for identifying the regulatory network. In this study, we used Affymetrix GeneChip Rice Genome Array to analyze eQTLs in rice flag le...

ORGANISM(S): Oryza sativa

2014-02-05 | E-GEOD-49020 | biostudies-arrayexpress

Previous page
1 / 5
You're on page 1
page 2
page 3
page 4
page 5
Next page

Sort by:

Relevance

Page size

49 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets